📈

Health Care Sector News Sector

Latest news, company updates, and analysis from the Health Care Sector News sector

Latest Health Care Sector News News

Clinuvel Pharmaceuticals Shares Slide Despite Strong Profit Margins — Is the Market Missing Value or Pricing In Real Risk?

Clinuvel Pharmaceuticals Shares Slide Despite Strong Profit Margins — Is the Market Missing Value or Pricing In Real Risk?

Shares in Clinuvel Pharmaceuticals (ASX:CUV) have had a rough stretch, closing recently at A$8.47 after declines over th...

Explaining ASX Healthcare Shares: Biotechnology To Medical Equipment and Why It Matters To Investors

Explaining ASX Healthcare Shares: Biotechnology To Medical Equipment and Why It Matters To Investors

The healthcare sector has spent much of 2026 going against the expectations associated with it. Healthcare is meant to b...

ASX: RAD's Busy 2026: Inside Radiopharm's Pipeline of Upcoming Clinical Data Readouts

ASX: RAD's Busy 2026: Inside Radiopharm's Pipeline of Upcoming Clinical Data Readouts

Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX) has entered 2026 as one of the more closely watched names on the ASX's...

ASX: BXN Bioxyne's $50M German Cannabis Deal — Is the 295% Rally Justified?

ASX: BXN Bioxyne's $50M German Cannabis Deal — Is the 295% Rally Justified?

Bioxyne (ASX: BXN) has locked in a $50 million, two-year exclusive supply agreement with German pharmaceutical distribut...

ASX Healthcare Stocks in Focus: Strategic Alliances, Financial Updates and Expansion Plans

ASX Healthcare Stocks in Focus: Strategic Alliances, Financial Updates and Expansion Plans

The following ASX listed firms have been making key moves through strategic alliances, business development, technology...

Which ASX Healthcare Stocks Have Clinical Trials Running in June 2026?

Which ASX Healthcare Stocks Have Clinical Trials Running in June 2026?

The coming June 2026 will likely prove to be one of the most eventful months ever for ASX healthcare stocks. In fact, th...

Cochlear in 2026 — Ugly Short Term, But Is the Story Broken?

Cochlear in 2026 — Ugly Short Term, But Is the Story Broken?

Down 61% for the year. Guidance slashed nearly in half. It has been a really rough stretch for COH shareholders. But ste...